The value of the Omega 3 Fatty Acid market is projected to grow to US$ 10,250.0 Mn with an estimated CAGR of 8.3% by 2032
.jpg "The Global Omega 3 Fatty Acids Market 2022-2032 (USD Million)")
Positive clinical studies, as well as rising health awareness, regulatory recognition, and rising living standards in various countries, will boost the worldwide Omega 3 fatty acids market forward in the future years. Omega-3 fatty acids, also known as n3 fatty acids, 3 fatty acids, and omega-3 oils, are polyunsaturated fatty acids (PUFAs). Plant sources, such as walnuts, edible seeds, clary sage seed, flaxseed, Sacha Inch, Echium, hemp, and others, and animal sources, such as fish, chicken eggs, squid, krill, and specific algae, are the two main sources of omega-3 fatty acids. Lowering the risk of diseases and disorders such cancer, asthma, cardiovascular disease, atopic diseases, inflammation, cognitive ageing, brain and visual functioning, mental health, developmental disabilities, and insufficiency is expected to boost omega 3 fatty acid demand during the next few years. Increased demand for omega-3 polyunsaturated fatty acids in pharmaceuticals and functional foods, rising awareness of healthcare and chronic diseases, and expanding application profiling of omega-3 are some of the factors driving the worldwide omega-3 fatty acid market's rise. Several pharmaceutical companies have already begun to use higher doses of omega-3 in their products, and more companies are expected to enter the omega-3 medicine industry in the future.
In terms of demand, supplements and functional foods emerged as the most popular application segment in North America. Omega 3 is particularly beneficial in the treatment of a range of health disorders, including depression, bone loss, menstrual health, and mental health, which has led to a surge in its use in the aforementioned application category. Over the next few years, changing consumer lifestyles and increased worries about health issues, particularly coronary heart disease and developmental disorders, are projected to fuel product demand even more. Proven benefits of omega 3, notably for cardiovascular diseases, are expected to stimulate demand for omega 3-based pharmaceutical products over the projected period, as are rising cases of cardiovascular diseases among all age groups globally.
The market is highly concentrated and competitive, with major global companies are also investing in the acquisition of cargo vessels in order to obtain a strategic advantage and assure a steady supply of raw materials. Aker BioMarine, Axellus, BASF SE, DSM, Omega Protein Corporation, GC Reiber Oils, and Lonza are some of the leading market participants. North America was the biggest consumer of omega-3 supplements, followed by Europe. Regulations encouraging the use of omega-3 fatty acids in functional foods and infant formula are predicted to boost demand for omega-3 fatty acids in industrialized countries. The omega-3 fatty acid market in Asia-Pacific is predicted to develop at the quickest rate in the coming years. The need for omega-3 products, such as infant formula and nutritional supplements, is predicted to rise in emerging countries as their populations grow. In addition, changing lifestyles and health concerns (especially coronary heart disease, dyslipidemia, and developmental abnormalities) are predicted to boost demand for omega-3 fatty acids. From 2016 through 2028, this research article revenue growth at the global, regional, and country levels, as well as an analysis of the most recent market trends and prospects in each sub-segment.
Omega 3 Fatty Acid Market Scope
| Metrics | Details |
| Base Year | 2023 |
| Historic Data | 2018-2022 |
| Forecast Period | 2024-2032 |
| Study Period | 2018-2032 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2032 | US$ 10,250.0 Mn |
| Growth Rate | CAGR of 8.3 % during 2022-2032 |
| Segment Covered | By Source, by Application, By Form, Regions |
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
| Key Players Profiled | BASF SE, FMC Corporation, The Dow Chemical Company, Koninklijke DSM NV, Enzymotec Ltd., Croda International Plc, Omega Protein Corporation, Aker BioMarine AS, Polaris Nutritional Lipids, Cargill, Incorporated, Arista Industries, Nutrifynn Caps, Inc., Sea Dragon Ltd., Lysi hf., GC Rieber Oils AS, Bizen Chemical Co. LTD, Maruha Nichiro Corporation, Olvea Fish Oils, Arctic Nutrition AS, Golden Omega |
Key Segments of the Omega 3 Fatty acid Market
Type Overview (USD Million)
- Docosahexaenoic acid (DHA)
- Eicosapentaenoic acid (EPA)
- Alpha-linolenic acid (ALA)
Application Overview, (USD Million)
- Supplements & Functional Foods
- Pharmaceuticals
- Infant Formulas
- Animal Feed & Pet Food
- Others
Source overview, (USD Million)
- Marine Source
- Plant Source
Regional Overview, (USD Million)
- North America
- US
- Canada
- Mexico
- Europe
- France
- UK
- Germany
- Italy
- Norway
- The Netherlands
- Spain
- Rest of Europe
- APAC
- China
- Australia and New Zealand
- Japan
- India
- Rest of APAC
- MEA
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Reasons for the study
- To profile major companies in the market and thoroughly examine their fundamental strengths.
- To offer a thorough competitive landscape of the market, as well as a study of leading market competitors' business and corporate strategies, such as mergers and acquisitions, new product launches and advancements, and expansions.
- The study examines the global Omega 3 fatty acids market's dynamics and migration across several geographies.
- We discovered that the demand for Omega 3 fatty acids products was enormous in both developed and emerging countries while researching the market.
- To address the increased demand and overcome the overfishing problem, the corporations are developing new manufacturing facilities, particularly algae-based Omega 3 fatty acids extraction processes.
What does the report include?
- In-depth market segmentation based on trends, growth, and historical and forecast data.
- The scope of the report includes a market strategic analysis of future prospects, individual growth patterns, and the contributions of important sub-market stakeholders.
- The research focuses on the market for Omega 3 fatty acids and the businesses that use them.
- The qualitative aspects of the report on the worldwide Omega 3 fatty acids market include value chain analysis, drivers, and constraints.
- The research includes a qualitative and quantitative analysis of the market, which is split into applications. Furthermore, the study gives comparable data for the relevant geographies.
- For all of the above-mentioned segments, actual market sizes and predictions have been presented.
- Profiles of prominent market players having a large worldwide and/or regional presence are included in the report.
Who should buy this report?
- The precise market valuation, which includes size, share, and revenue, are also addressed for a better knowledge of the market position.
- The study on the global Omega 3 fatty acids market is appropriate for all stakeholders in the value chain, including food, pharmaceuticals, and other industries.
- Investors and venture capitalists interested in learning more about the global market for Omega 3 fatty acids.
- Consultants, analysts, researchers, and academics interested in learning more about the global Omega 3 fatty acids market.
Frequently Asked Questions (FAQ) :
The market value of omega 3 fatty acids market in 2032 was US$ 10,250.0 Mn
The major contenders in the global market are Aker BioMarine, Axellus, BASF SE, DSM, Omega Protein Corporation, GC Reiber Oils, and Lonza.
The Global omega 3 fatty acids market is Segmented on the By Source, by Application, By Form, Regions.
Polyunsaturated fatty acids (PUFAs) with a carbon double bond in their organic structure are known as omega-3 fatty acids. Meat, eggs, seal oil, krill, fish, and mammalian brains and eyes are examples of plants and marine life that contain these compounds. Eicosapentaenoic acid/docosahexaenoic acid (EPA/DHA) is the most prevalent and commonly used dietary form of omega-3 fatty acids, with a high proportion of EPA/DHA. Omega-3 fatty acids are health-promoting essential fatty acids that the body cannot make but are required for normal metabolic processes and functioning. In terms of demand, supplements and functional foods emerged as the most popular application segment in North America. Omega 3 is particularly beneficial in the treatment of a range of health disorders, including depression, bone loss, menstrual health, and mental health, which has led to a surge in its use in the aforementioned application category.
The world's increasing economic development, the worldwide Omega 3 fatty acids market will do well. In addition, the market for Omega 3 fatty acids would develop due to an increase in demand for supplements and functional foods over the forecast period. Emerging economies, such as India, China, and other Asian countries, are increasing their expenditure in the pharmaceutical sector, luring large market players to invest in these areas. However, the restricted supply of fish that contains Omega 3 fatty acids, as well as increased levels of contamination in fish, may function as a stumbling block to the market's expansion. Supplements and functional foods use the most Omega 3 fatty acids oil, followed by pet and animal feed, newborn formulae, and medications.
Pharmaceuticals, infant formulae, and pet & animal feed follow supplements & functional food in terms of value. Because of the multiple nutritional benefits necessary for infant growth, the infant formula segment is predicted to increase at the fastest rate during the projection period. DSM, BASF, Croda, Pronova, Omega Protein, and others are among the worldwide as well as regional competitors competing in the global Omega 3 fatty acids market. These major players have always aspired to adopt cutting-edge strategies through strategic alliances, collaborations, and corporate expansions.
Type Segment
The market is divided into three types: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA) (ALA). The combination of DHA and EPA helps to lower bad cholesterol and coronary heart illnesses like strokes and blood pressure, which is projected to drive growth in these categories. Rising rates of heart disease among people as a result of a sedentary lifestyle are expected to drive up demand for omega 3. Increasing aquaculture activities, particularly in Asia Pacific, are expected to stimulate demand for omega 3 feeds, thanks to sufficient farmed land and excellent climatic conditions.
Application Segment
Supplements & functional foods, pharmaceuticals, quick formulas, pet & animal feed, and other applications make up the worldwide omega 3 market. Because of the multiple health benefits of omega 3, rising R&D initiatives, and rising healthcare expenses, the supplements & functional foods segment dominated the industry in 2019. Adults' increasing use of dietary supplements to maintain fitness and nutrient sufficiency is expected to increase omega 3 usage in dietary supplement products. The pharmaceutical industry's widespread use of omega 3 is expected to drive the pharmaceutical application segment in the coming years. Omega 3 is used to treat depression, cancer, Alzheimer's, osteoporosis, and cardiovascular illnesses due to its anti-inflammatory effects. Furthermore, the segment is expected to be driven by an increase in the use of omega 3 in the production of pharmaceutical-grade capsules to treat obesity.
Source Segment
The omega 3 industry is divided into two categories based on the source: marine sources and plant sources. Consumer interest in omega 3 fatty acids produced from fish and krill oils is driving demand for marine-based products. Over the next few years, the category is expected to be driven by rising consumption of omega 3 in the form of fortified food products such fish ham and fish sausages. Furthermore, as people become more aware of the dangers of high triglyceride diets, demand for omega 3-fortified foods is expected to rise. Human physiology is made up of three forms of omega 3 fatty acids: docosahexaenoic acid, eicosapentaenoic acid, and alpha-linolenic acid. The first two omega 3 acids are usually found in marine oils, whereas alpha-linolenic acid is primarily found in plant oils. Due to the scarcity of EPA and DHA in plant-based sources, major players in the industry are developing marine-based EPA and DHA products.
Because of increased product usage in the pharmaceutical business and increased research and development activities, North America emerged as the largest market in 2019. Furthermore, increased demand for enhanced medications, as well as the need to extend the lives of the region's elderly population, are likely to drive demand for omega 3-based pharmaceutical goods in the region. Due to increased demand for the product in countries like as China, India, Singapore, South Korea, Australia, and Japan, the Asia Pacific is expected to grow significantly over the projection period. The demand for omega 3 in this region is increasing as people consume more fish oil in their regular diets and become more mindful of their health. Furthermore, expanding krill fish aquaculture in the South China Sea and the Indian Ocean is likely to drive regional market expansion in the coming years. Western Europe, which includes nations like Belgium, Spain, and Portugal, is expected to have an ageing population that accounts for more than 20% of the world population, resulting in an increase in healthcare spending in the region. Furthermore, because to its rising use in the pharmaceutical, pet & animal feed, and newborn nutrition industries, the area has a major proportion of demand for omega 3.